A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody
Global efforts on the replacement of the in vivo rabies vaccine potency test (NIH method) with in vitro methods for quantification of immunodominant glycoprotein (GP) in rabies vaccine have made significant progress. We report here, a sandwich ELISA method based on the use of a neutralizing rabies G...
Saved in:
Main Authors: | Sunil Gairola (Author), Manish Gautam (Author), Satish Waghmare (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies.
by: Lara Schöler, et al.
Published: (2022) -
Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
by: Jihye Um, et al.
Published: (2017) -
Utility of rabies neutralizing antibody detection in cerebrospinal fluid and serum for ante-mortem diagnosis of human rabies.
by: Tina Damodar, et al.
Published: (2019) -
In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom
by: Line Ledsgaard, et al.
Published: (2022) -
Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines
by: Tania Maria Manieri, et al.
Published: (2022)